Boronate affinity technology utilises covalent binding of all cis-diols of glucose to hemoglobin using a boronate matrix. This specific binding allows the complete separation of the glycated and non-glycated haemoglobin fractions.
Overall this provides a patient result with:
In line with the ADA/EASD/IDF Working Group on HbA1c recent guidelines for reporting HbA1c, the Tri-stat is certified to report in the following units: